Segment Information (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Schedule of Segment Information

The following table is a summary of segment information for three and nine months ended September 30, 2021 and 2020 (amounts in thousands): 

	For the three months ended						For the nine months ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Net revenues
Diagnostic services	$	7,142		$	-		$	27,416		$	-
Consumer products		2,330			3,840			6,469			9,351
Consolidated net revenue		9,472			3,840			33,885			9,351
Cost of revenue
Diagnostic services		4,009			-			11,833			-
Consumer products		1,486			2,798			4,682			6,615
Consolidated cost of revenue		5,495			2,798			16,515			6,615
Depreciation and amortization expense
Diagnostic services		401			-			1,138			-
Consumer products		-			3			6			13
Total Depreciation and amortization expense		401			3			1,144			13
Operating and other expenses		13,020			1,608			20,542			4,031
Income (loss) from continuing operations, before income taxes
Diagnostic services		(1,145	)		-			2,859			-
Consumer products		(958	)		1,039			(453	)		2,723
Unallocated corporate		(1,875	)		(1,608	)		(6,722	)		(4,031	)
Total loss from continuing operations, before income taxes		(3,978	)		(569	)		(4,316	)		(1,308	)
Income from discontinued operations, before income taxes		-			161			-			161
Net loss	$	(3,978	)	$	(408	)	$	(4,316	)	$	(1,147	)

The following table is a summary of segment balance sheets information as of September 30, 2021 and December 31, 2020 (in thousands):

	September 30,		December 31,
	2021		2020
ASSETS
Diagnostic services	$	28,738	$	13,410
Consumer products		20,986		6,261
Unallocated corporate		22,906		11,734
Total assets	$	72,630	$	31,405